We know that anti-inflammatory drugs are not without risk to health. Thus, in September 2018, Diclofenac was accused of doubling the risk of myocardial infarction; in August 2017, it was discovered that Ibuprofen could slow down the development of muscle mass.
This time, it is Prednisolone which is on the dock: prescribed against arthritis, asthma, allergies or even ear infections, it is a glucocorticoid.
Solupred®, Prednisolone®, Deliproct®, Derinox® … According to a study presented on November 11, 2019 at the annual conference of the Society for Endocrinology (in the UK) these medicines may increase the risk of developing diabetes.
Prednisolone: a negative impact (in the very short term) on blood sugar
To reach this conclusion, researchers at Sapienza University of Rome (Italy) and University of Oxford (England) worked with a group of patients, 16 men treated with Prednisolone 10 and 15 mg for 7 days.
Verdict? The researchers found that after just a week of treatment, the drug disrupted the blood sugar regulatory mechanism, that is, the level of glucose in the blood.
” Even in small doses and very short term, this anti-inflammatory drug (which is very common) has a negative impact on the metabolism of glucose in the body, which suggests an increased risk of developing diabetes if the drug is continued. processing “say the researchers.
As a reminder, 3.7 million French people benefit from treatment against diabetes – in 90% of cases, it is type 2 diabetes, or “diabetes mellitus”.
Read also :
Osteoarthritis: 4 effective pain relieving herbs
5 foods that can help you have less pain
Avocado kernel is believed to have anti-inflammatory properties
